An editorial released by the Boston’s Globe’s editorial board on Thursday, April 14th, 2016, calls for insurance providers to allow unfettered access to the Hepatitis C cure for all living with the disease.
“Don’t deny hepatitis C patients a cure” follows an article published in the previous Sunday’s Boston Globe, “Hepatitis C drug costs leave many without care,” which also includes quotes from CHLPI’s Robert Greenwald.
Excerpt from article:
“’If there was a cure for Alzheimer’s or multiple sclerosis and we restricted treatment, there would be a huge outcry,’ says Robert Greenwald, director of the Center for Health Law and Policy Innovation at Harvard Law School.
Preventing the ravages of hepatitis C also could stem a disturbing trend reported last month by the federal Centers for Disease Control and Prevention — a nationwide rise in the number of liver cancer cases, about half of which are caused by hepatitis C.”